| Cover | Aug. 03, 2023 |
| Document Information [Line Items] | |
| Document Type | 8-K |
| Document Period End Date | Aug. 03, 2023 |
| Entity Registrant Name | Vir Biotechnology, Inc. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-39083 |
| Entity Tax Identification Number | 81-2730369 |
| Entity Address, Address Line One | 499 Illinois Street |
| Entity Address, Address Line Two | Suite 500 |
| Entity Address, City or Town | San Francisco |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94158 |
| City Area Code | 415 |
| Local Phone Number | 906-4324 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common stock, $0.0001 par value |
| Trading Symbol | VIR |
| Entity Emerging Growth Company | false |
| Amendment Flag | false |
| Entity Central Index Key | 0001706431 |
| NASDAQ - ALL MARKETS | |
| Document Information [Line Items] | |
| Security Exchange Name | NASDAQ |
